COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
Crossref DOI link: https://doi.org/10.1007/s00134-021-06499-8
Published Online: 2021-08-03
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rouzé, Anahita
Lemaitre, Elise
Nseir, Saad https://orcid.org/0000-0002-7618-0357
Text and Data Mining valid from 2021-08-03
Version of Record valid from 2021-08-03
Article History
Accepted: 28 July 2021
First Online: 3 August 2021
Declarations
:
: SN: MSD, Gilead, Pfizer, Biomérieux, Mio Rad, Fischer and Paykel (lecture). Other authors: none.
Free to read: This content has been made available to all.